the application of 5 - aminosalicyclic acid (5 asa) for the manufacture of a pharmaceutical preparation for use in the reperfusion therapy

摘要

The compound 5-aminosalicyclic acid (5-ASA), which may be used for treatment of colitis ulcerosa and Crohn's disease, has been found also to be useful in reperfusion treatment in connection with coronary circulation diseases and their complications, such as coronary sclerosis, coronary thrombosis, variant angina, unstable angina and myocardial infarct of any origin, partly as acute intervening treatment and partly as prophylactic treatment, including prophylaxis in thrombolytic treatment, angioplastic and coronary by-pass operation. For such uses, the compound is administered intravenously and/or orally.